Search results for: 'Cancer Diagnostics Market, liquid biopsy'
- Related search terms
- cancer vaccine market
- cancer vaccines market
- cancer immunotherapy global market
- diagnostics market outlook series
- cancer immunotherapi global market
-
21 Jul 2026  |  Global  |  Market Research
Point-of-Care Testing Market, Global, 2024–2031
The POCT Market is Experiencing Transformational Growth, Driven by Decentralized Molecular Diagnostics, Ultra-rapid Testing, and Connected Clinical Intelligence Ecosystems
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...
$2,450.00 -
22 May 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced RNA Therapies, Cancer Vaccines, Immunotherapies, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...
$950.00 -
18 Apr 2025  |  Global  |  Technology Research
Recent Advances in Biomanufacturing, Diagnostics and Precision Medicine
Innovations in Drug Design, Discovery, and Development
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers insights across biomanufacturing, targeted drug delivery, imaging, precision medicine and biologics innovations.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and ...
$950.00
Special Price $855.00 save 10 %
-
19 Jul 2024  |  Global  |  Technology Research
Technology Innovations in Diagnostics, Drug Discovery, Biologics and Drug Delivery Systems
Life Science, Health & Wellness Technology Opportunity Engine (TOE)
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...
$950.00
Special Price $712.50 save 25 %
-
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
03 Apr 2025  |  Global  |  Technology Research
Emerging Opportunities for Quantum Sensing in Healthcare
Revolutionizing Diagnostics and Personalized Medicine with Quantum Technology
The opportunities that come with the utilization of quantum sensing technology in healthcare demonstrate significant potential to revolutionize diagnostics, personalized medicine, and drug development. Quantum sensors offer superior sensitivity and precision, enabling earlier disease detection, easier and non-intrusive monitoring, and producing bet...
$4,950.00
Special Price $4,455.00 save 10 %
-
14 Feb 2025  |  Global  |  Technology Research
Technological Advances in Cancer Biologics and Precision Medicine Strategies
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...
$950.00
Special Price $855.00 save 10 %
-
14 Jun 2024  |  Global  |  Technology Research
Recent technology innovations for the management of infectious diseases, cancer and immunological disorders
Life Science, Health & Wellness Technology Opportunity Engine (TOE)
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...
$950.00
Special Price $712.50 save 25 %
-
18 Sep 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...
$950.00 -
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00